Immunogenicity Risk Assessment for an Engineered Human Cytokine Analogue Expressed in Different Cell Substrates
Crossref DOI link: https://doi.org/10.1208/s12248-020-00443-2
Published Online: 2020-04-14
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chamberlain, Paul http://orcid.org/0000-0002-8273-140X
Rup, Bonita
Text and Data Mining valid from 2020-04-14
Version of Record valid from 2020-04-14
Article History
Received: 26 November 2019
Accepted: 2 March 2020
First Online: 14 April 2020